Prestigious Award Honors Groundbreaking Immune System Research
The prestigious award in medical science was awarded for revolutionary findings that illuminate how the body's defense network attacks dangerous infections while protecting the healthy tissues.
Three renowned scientists—from Japan Shimon Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—share this accolade.
Their work uncovered specialized "sentinels" within the defense system that remove rogue immune cells that could harming the body.
These discoveries are now paving the way for innovative treatments for autoimmune diseases and cancer.
These laureates will share a monetary award valued at 11 million SEK.
Decisive Discoveries
"The work has been essential for understanding how the body's defenses functions and why we do not all develop serious self-attack conditions," commented the head of the award panel.
The trio's research address a fundamental mystery: In what way does the defense system protect us from numerous invaders while keeping our healthy cells intact?
The body's protection system uses immune cells that search for indicators of infection, including viruses and germs it has never encountered.
Such cells utilize sensors—known as receptors—that are produced by chance in a vast number of combinations.
That provides the defense network the capacity to combat a broad range of threats, but the randomness of the process inevitably creates immune cells that may target the host.
Security Guards of the Immune System
Researchers previously understood that some of these harmful defense cells were destroyed in the thymus—where immune cells develop.
The latest Nobel Prize recognizes the identification of T-reg cells—described as the immune system's "security guards"—which travel through the system to disarm other immune cells that attack the body's own tissues.
It is known that this mechanism malfunctions in autoimmune diseases such as juvenile diabetes, MS, and RA.
The Nobel panel stated, "The discoveries have laid the foundation for a new field of research and accelerated the creation of new therapies, for instance for tumors and immune disorders."
Regarding malignancies, regulatory T-cells block the system from attacking the tumor, so research are aimed at reducing their numbers.
In self-attack disorders, trials are testing increasing T-reg cells so the body is not under attack. A comparable approach could also be effective in minimizing the risks of organ transplant rejection.
Pioneering Experiments
Prof Shimon Sakaguchi, of Osaka University, conducted experiments on rodents that had their immune gland extracted, leading to autoimmune disease.
The researcher showed that introducing defense cells from other animals could prevent the disease—implying there was a mechanism for blocking immune cells from harming the body.
Dr. Brunkow, from the a research center in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were investigating an inherited autoimmune disease in mice and humans that led to the discovery of a gene vital for how regulatory T-cells function.
"The pioneering work has revealed how the body's defenses is kept in check by regulatory T cells, preventing it from mistakenly attacking the healthy cells," commented a leading biological science expert.
"This work is a remarkable illustration of how fundamental physiological research can have broad consequences for human health."
